News|Podcasts|August 2, 2023
The Business Case for Patient Centricity
Author(s)ZS Associates
Sharon Suchotliff, associate principal at ZS and lead for patient centricity, discusses why patient centricity has become a business imperative for life sciences companies. Sharon delves into the measurement of patient centricity, provides examples of how different companies have approached this and ZS’s approach for Patient Outcomes Impact (POI).
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
Novartis Planning Layoffs for 550 Positions at Switzerland Facility
2
Next-Gen CDMOs: Keeping Pace With Industry Change
3
Pharmaceutical Executive Daily: Moderna's $1.5 Billion Loan
4
Aidoc Submits Breakthrough-Designated Multi-Triage Device for FDA Approval
5
